CAI
BIIB icon

Capital Advisors Inc’s Biogen BIIB Stock Holding History

Capital Advisors Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-837
Closed -$238K – 265
2023
Q2 		$238K Buy
+837
New +$249K 0.01% 243
2016
Q3 		– Sell
-21,776
Closed -$5.27M – 136
2016
Q2 		$5.27M Buy
21,776
+1,792
+9% +$472K 0.82% 57
2016
Q1 		$5.2M Buy
19,984
+1,078
+6% +$285K 0.85% 54
2015
Q4 		$5.79M Buy
18,906
+6,304
+50% +$1.81M 1.01% 49
2015
Q3 		$3.68M Buy
12,602
+569
+5% +$188K 0.66% 62
2015
Q2 		$4.86M Buy
+12,033
New +$4.83M 0.83% 53

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Advisors Inc's BIIB Position: Q3 2023 in Review

Capital Advisors Inc sold out of Biogen (BIIB) in Q3 2023, closing a stake of 837 shares — an estimated $238K sold.

Capital Advisors Inc first reported a position in BIIB in Q2 2015 and held it in 6 quarters. The position peaked at $5.79M in Q4 2015. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Capital Advisors Inc reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Capital Advisors Inc sold 837 Biogen shares in Q3 2023, an estimated $238K.
  • Capital Advisors Inc first reported a position in Biogen in Q2 2015 and held it in 6 quarters.
  • Capital Advisors Inc's Biogen position peaked at $5.79M in Q4 2015.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Capital Advisors Inc's 13F filing for Q3 2023, filed 24 Oct 2023.